Table 2

Biological, virological, and immunological outcomes of human immunodeficiency virus-hepatitis C virus (HIV-HCV) coinfected patients receiving interferon and ribavirin therapy

	Baseline	Month 3	p Value^2-150	Month 6	p Value^2-150
n^2-151	21	21		17
Haemoglobinaemia (g/dl)
Median (range)	13.8 (10.5–16.7)	11.8 (7.8–16)	0.0002	11.8 (5–16)	0.0003
n^2-151	21	21		17
RNA HIV (log10 copies/ml)	2.3 (2.3–4.9)	2.3 (2.3–4.6)	0.3	2.3 (2.3–4.7)	0.6
HIV RNA negative (n (%))	12 (57)	10 (47.6)		10 (47.6)
CD4 (cells/ml)
n^2-151	21	21		17
Median (range)	330 (55–600)	336 (32–639)	0.6	298 (55–507)	0.2
HCV PCR
n^2-151	21	21		17
No patients with negative PCR (%)	0 (0)	10 (47)		6 (35)

↵2-150 Compared with baseline.
↵2-151 Number of tested patients.